The Short Answer
Cataract surgery (15-minute outpatient procedure, 99% success), diabetic retinopathy control (HbA1c <7%, blood pressure <130/80), macular degeneration treatment (antioxidants, zinc, anti-VEGF injections), and corrective lenses all preserve or restore sight. Early intervention prevents 50% of blindness [1][5].
Cataract surgery removes the cloudy lens and replaces it with a clear plastic implant. The procedure takes 15 minutes, costs $3,000–$5,000 per eye (Medicare covers 80%), and restores vision in 95% of patients within weeks. Diabetic retinopathy is managed by tight glucose and blood pressure control; if bleeding occurs, laser surgery or anti-VEGF injections (Avastin, Lucentis) stop leaks [1][5].
Macular degeneration slows with daily antioxidants (vitamins C, E, zinc, lutein) and omega-3 fish oil—a 50% progression reduction in clinical trials. Anti-VEGF injections (Eylea, Avastin) cost $1,500–$2,000 per injection but are covered by Medicare for wet macular degeneration. Corrective lenses, magnifiers, and screen-reading software help low-vision patients stay independent [3][6].
Glaucoma is managed with daily eye drops (timolol, latanoprost, dorzolamide) that lower eye pressure by 20–30%. Drops cost $10–$50 monthly; Medicare covers most. If drops fail, laser or surgical procedures prevent optic nerve damage. Never skip doses—missing even one week can cause permanent vision loss [9].